Zimmer Biomet Holdings, Inc. <ZBH.N>: UBS Raises Target Price to $120 from $115
ZBH•Related News
Horizon Kinetics Asset Management reports RENN Fund common share buy valued at $2,245.32
RCG•
Sight Sciences, Inc. <SGHT.O>: UBS raises target price to $8 from $7
SGHT•
Insulet Corporation <PODD.O>: UBS Cuts Target Price to $150 From $174
PODD•
Creative Medical gets USPTO notice of allowance for exosome-based Type 1 diabetes immunotherapy patent application
CELZ•
Camden National Q2 FY26 net income rises 63% to $23.02 million
CAC•